Literature DB >> 32876014

No Evidence of Acute Dengue Virus Infections at a Rural Site in Western Kenya, 2011 and 2013.

Alastair I Matheson1,2, Ondari D Mogeni3, Joshua R Lacsina4, Melvin Ochieng5, Allan Audi6, Godfrey Bigogo6, John Neatherlin5, Harold S Margolis7, Barry Fields8, Petronella Ahenda9, Judd L Walson4,1,2, Joel M Montgomery8.   

Abstract

The incidence and spread of dengue virus (DENV) have increased rapidly in recent decades. Dengue is underreported in Africa, but recent outbreaks and seroprevalence data suggest that DENV is widespread there. A lack of ongoing surveillance limits knowledge about its spatial reach and hinders disease control planning. We sought to add data on dengue distribution in Kenya through diagnostic testing of serum specimens from persons with an acute febrile illness (AFI) attending an outpatient clinic in rural western Kenya (Asembo) during rainy seasons. Patients with symptoms not likely to be misclassified as dengue (e.g., diarrhea and anemia), those with a positive diagnostic laboratory results which explained their febrile illness, or those with serum collected more than 5 days after fever onset were excluded. However, febrile patients with a positive malaria smear were included in the study. We used reverse transcription polymerase chain reaction (RT-PCR) to test for DENV and IgM anti-DENV to test for recent infection. Of the 615 serum specimens available for testing, none were dengue positive by either RT-PCR or IgM anti-DENV testing. Dengue did not appear to be a cause of febrile illness in this area of western Kenya, although our relatively small sample size may not have identified DENV infections occurring at low incidence. A more widespread AFI surveillance system that includes dengue diagnostic testing by RT-PCR and antibody-based methods is required to more definitively gauge the size and geographic distribution of DENV infection in western Kenya.

Entities:  

Mesh:

Year:  2020        PMID: 32876014      PMCID: PMC7646792          DOI: 10.4269/ajtmh.20-0132

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  49 in total

1.  Efficacy of a tetravalent dengue vaccine in children in Latin America.

Authors:  Luis Villar; Gustavo Horacio Dayan; José Luis Arredondo-García; Doris Maribel Rivera; Rivaldo Cunha; Carmen Deseda; Humberto Reynales; Maria Selma Costa; Javier Osvaldo Morales-Ramírez; Gabriel Carrasquilla; Luis Carlos Rey; Reynaldo Dietze; Kleber Luz; Enrique Rivas; Maria Consuelo Miranda Montoya; Margarita Cortés Supelano; Betzana Zambrano; Edith Langevin; Mark Boaz; Nadia Tornieporth; Melanie Saville; Fernando Noriega
Journal:  N Engl J Med       Date:  2014-11-03       Impact factor: 91.245

2.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.

Authors:  R S Lanciotti; C H Calisher; D J Gubler; G J Chang; A V Vorndam
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

3.  Evaluation of diagnostic tests: dengue.

Authors:  Rosanna W Peeling; Harvey Artsob; Jose Luis Pelegrino; Philippe Buchy; Mary J Cardosa; Shamala Devi; Delia A Enria; Jeremy Farrar; Duane J Gubler; Maria G Guzman; Scott B Halstead; Elizabeth Hunsperger; Susie Kliks; Harold S Margolis; Carl M Nathanson; Vinh Chau Nguyen; Nidia Rizzo; Susana Vázquez; Sutee Yoksan
Journal:  Nat Rev Microbiol       Date:  2010-12       Impact factor: 60.633

4.  Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.

Authors:  Maria Rosario Capeding; Ngoc Huu Tran; Sri Rezeki S Hadinegoro; Hussain Imam H J Muhammad Ismail; Tawee Chotpitayasunondh; Mary Noreen Chua; Chan Quang Luong; Kusnandi Rusmil; Dewa Nyoman Wirawan; Revathy Nallusamy; Punnee Pitisuttithum; Usa Thisyakorn; In-Kyu Yoon; Diane van der Vliet; Edith Langevin; Thelma Laot; Yanee Hutagalung; Carina Frago; Mark Boaz; T Anh Wartel; Nadia G Tornieporth; Melanie Saville; Alain Bouckenooghe
Journal:  Lancet       Date:  2014-07-10       Impact factor: 79.321

5.  Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control.

Authors:  Robert W Snow; Eliud Kibuchi; Stella W Karuri; Gilbert Sang; Caroline W Gitonga; Charles Mwandawiro; Philip Bejon; Abdisalan M Noor
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

6.  Investigation of laboratory confirmed Dengue outbreak in North-eastern Kenya, 2011.

Authors:  Mark Obonyo; Ahmed Fidhow; Victor Ofula
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

7.  Unrecognized Dengue Virus Infections in Children, Western Kenya, 2014-2015.

Authors:  David M Vu; Noah Mutai; Claire J Heath; John M Vulule; Francis M Mutuku; Bryson A Ndenga; A Desiree LaBeaud
Journal:  Emerg Infect Dis       Date:  2017-11       Impact factor: 6.883

8.  Laboratory systems and services are critical in global health: time to end the neglect?

Authors:  John N Nkengasong; Peter Nsubuga; Okey Nwanyanwu; Guy-Michel Gershy-Damet; Giorgio Roscigno; Marc Bulterys; Barry Schoub; Kevin M DeCock; Deborah Birx
Journal:  Am J Clin Pathol       Date:  2010-09       Impact factor: 2.493

9.  Forecast of dengue incidence using temperature and rainfall.

Authors:  Yien Ling Hii; Huaiping Zhu; Nawi Ng; Lee Ching Ng; Joacim Rocklöv
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

10.  The global distribution and burden of dengue.

Authors:  Samir Bhatt; Peter W Gething; Oliver J Brady; Jane P Messina; Andrew W Farlow; Catherine L Moyes; John M Drake; John S Brownstein; Anne G Hoen; Osman Sankoh; Monica F Myers; Dylan B George; Thomas Jaenisch; G R William Wint; Cameron P Simmons; Thomas W Scott; Jeremy J Farrar; Simon I Hay
Journal:  Nature       Date:  2013-04-07       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.